Sun Pharmaceuticals Industries Ltd. ADR (SMPQY) Management on Q4 2022 Results
seekingalpha.com
finance
2022-05-30 18:02:05

Sun Pharmaceuticals Industries Ltd. ADR (OTCPK:SMPQY) Q4 2022 Results Conference Call May 30, 2022 9:00 AM ET Company Participants Nimish Desai - Head, IR Dilip Shanghvi - Managing Director C. S. Muralidharan - CFO Abhay Gandhi - CEO, North America Kirti Ganorkar - CEO, India Business Conference Call Participants Tarang Agrawal - Old Bridge Capital Neha Manpuria - Bank of America Damayanti Kerai - HSBC Securities and Capital Markets Kunal Dhamesha - Macquarie Krish Mehta - Enam Holdings Bino Pathiparampil - InCred Capital Sameer Baisiwala - Morgan Stanley Surya Patra - PhilipCapital Operator Ladies and gentlemen, good day, and welcome to the Q4 FY '22 Earnings Conference Call of Sun Pharmaceutical Industries Limited.
